Assistant Professor, Lorestan University of Medical Sciences, Iran
Dr. Milad Zandi is a prominent virologist and a lecturer at Lorestan University of Medical Sciences. Recognized among the top 2% scientists globally in 2024, he is a distinguished expert in medical virology and serves as a board member of the Iranian Society for Virology. Additionally, he coordinates the Iran Sector for the World Society of Virology. With extensive contributions to the field, Dr. Zandi has earned several awards for his groundbreaking research on viruses, including SARS-CoV-2 and monkeypox. His scholarly work spans high-impact journals and global collaborations. Dr. Zandi’s achievements include editorial positions in prestigious journals like Reviews in Medical Virology and Frontiers in Public Health. Passionate about advancing virological research, he has contributed to understanding viral immunology and vaccine development, earning acclaim for his insights into the interplay of viruses and host immunity. Dr. Zandi’s dedication underscores his role as a global influencer in virology
Profile
Education
Dr. Milad Zandi’s educational journey is rooted in excellence. He completed his Ph.D. in Medical Virology (2017–2022) at Tehran University of Medical Sciences, where his thesis focused on evaluating the adjuvanticity of cerium nanoparticles in animal rabies vaccines. He earned his M.Sc. in Medical Virology (2013–2016) from Ahvaz Jundishapur University of Medical Sciences, exploring recombinant protein production for rotavirus immunization in rabbit models. Earlier, he graduated with a B.Sc. in Microbiology (2009–2012) from Islamic Azad University, Sanandaj. Dr. Zandi achieved the 1st rank in the National Competition (2017-2018) and excelled academically, with a Ph.D. graduation score of 19.12/20 and an M.Sc. score of 17.11/20. His robust academic foundation reflects his passion for research and innovation in virology.
Experience
Dr. Milad Zandi is a lecturer in Medical Virology at Lorestan University of Medical Sciences and a dedicated member of the Iranian Society for Virology’s Board of Directors. Internationally, he contributes as a Membership Review Committee member and the Iran Sector Coordinator for the World Society of Virology. Dr. Zandi is also actively involved in editorial roles for esteemed journals, such as Reviews in Medical Virology (Associate Editor) and Frontiers in Public Health (Associate Editor), contributing to impactful virology discourse. His professional journey is defined by expertise in viral pathogenesis, immunology, and vaccine development. With a publication portfolio in high-impact journals and involvement in global research initiatives, Dr. Zandi has made significant contributions to SARS-CoV-2, monkeypox, and arbovirus studies. His commitment to bridging clinical application and academic insight has cemented his reputation as a leading voice in medical virology research.
Awards and Honors
Dr. Milad Zandi has earned numerous awards in recognition of his contributions to virology. In 2023, he received the Outstanding Scientist Award at the International Conference for Award Winners on Engineering, Science, and Medicine in India. Additionally, he was honored with the Best Researcher Award at the International Research Awards on New Science Inventions (January 2023) and the Neurology and Neuro Disorders Conference (December 2022, Dubai). His inclusion among the top 2% of scientists globally in 2024 highlights his exceptional research contributions. Dr. Zandi has also secured prestigious editorial roles in high-impact journals, reflecting his influence in the scientific community. These accolades underscore his commitment to advancing medical virology and his impactful contributions to viral immunology, vaccine development, and global health.
Research Focus
Dr. Milad Zandi’s research focuses on viral pathogenesis, immunology, and vaccine development. His Ph.D. work explored adjuvanticity of cerium nanoparticles for rabies vaccines, while his studies on SARS-CoV-2 have provided significant insights into immune evasion and accessory proteins. Dr. Zandi has extensively studied emerging infectious diseases, including monkeypox and arboviruses, and the role of microRNAs in viral infections. His systematic reviews have illuminated co-infections in COVID-19 patients and their clinical implications. Dr. Zandi has also contributed to biosensor development for virus diagnostics, blending innovative technology with virology. His multidisciplinary approach integrates immunoinformatics, nanotechnology, and public health perspectives, ensuring his research addresses critical global health challenges. Through collaborations and editorial roles, Dr. Zandi fosters impactful research dissemination and remains at the forefront of advancing virological science.
Publication
🌍 Global age-sex-specific mortality and population estimates (The Lancet, 2024)
- 🦠 An overview on the seven pathogenic human coronaviruses (2022)
- 💉 Design of a multi-epitope vaccine against SARS-CoV-2 (2020)
- 🧠 Monkeypox virus neurological manifestations (2022)
- 🔬 The role of miRNAs in COVID-19 disease (2021)
- 📚 COVID-19 mental and neurological symptoms: A meta-analysis (2021)
- 🛡️ The role of SARS-CoV-2 accessory proteins in immune evasion (2022)
- 🌎 Global fertility trends and demographic analysis (2024)
- 🧪 Clinical performance of RT-PCR and CT for COVID-19 diagnosis (2020)
- 🤧 Respiratory microbiota in COVID-19 patients (2021)
- ⚙️ Biosensors for field-ready SARS-CoV-2 diagnostics (2021)
- 🐒 State-of-the-art on monkeypox virus (2022)
- 🦠 Viral coinfection in COVID-19 patients (2021)
- 🩺 Systematic review on vulvovaginal candidiasis in Iran (2021)
- 🌍 Worldwide microbial coinfection in COVID-19 patients (2022)
- 🦠 Bacterial coinfection in COVID-19 patients (2021)
- 🧬 The role of microRNAs in viral infections (2018)
- 🛡️ ORF9c and ORF10 proteins in SARS-CoV-2 immune evasion (2022)
- 🐵 Human monkeypox and vaccine landscape (2023)
- 🧫 CRISPR-Cas system as a diagnostic tool for COVID-19 (2022)